Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Stopped early · Phase 3

Conditions studied: Alzheimer's Disease

In brief

Open-label treatment with MPC-7869 for participants in a previous randomized study.

Key facts

Study ID

NCT00380276

Run by

Myrexis Inc.

People needed

1000

Starts

2006-09-01

Expected to finish

2008-12-01

Last updated by the study team

2008-08-05

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participation in a previous MPC-7869 randomized protocol
• Have had a diagnosis of probable Alzheimer's disease.
• Men or women ages 55 years or greater and living in the community at the time of enrollment (i.e., not living in a rest home or nursing care facility).
• Signed the subject Informed Consent Form and is willing and able to participate for the duration of the study.
• Female subjects must be surgically sterile or postmenopausal for > 1 year.
• Subjects must have a reliable caregiver who can read, understand and speak English or Spanish.

You may not qualify if…

• History or evidence of, active malignancy, except for basal cell carcinoma or squamous cell carcinoma of the skin, within the 24 months prior to entry. Men with prostate cancer may be enrolled at the discretion of the sponsor.
• Chronic or acute renal, hepatic or metabolic disorder.
• Use of any investigational therapy within 30 days, or 5 half-lives, whichever is longer, and/or use of AD immunotherapy prior to screening.

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Sun City, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Costa Mesa, California, United States
• Study site — Irvine, California, United States
• Study site — Lafayette, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Long Beach, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — Vista, California, United States
• Study site — Danbury, Connecticut, United States
• Study site — Darien, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Deerfield Beach, Florida, United States
• Study site — Fort Meyers, Florida, United States
• Study site — Fort Myers, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.